Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease

Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease

US Patent 12030862 · Granted Jul 9, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibiting (α-v)(β-6) integrin2025
Aminopyrimidine derivatives as phosphatidylinositol phosphate kinase inhibitors2024
Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhib2024
Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhib2024
Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the tre2024
Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the tre2024
Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the tre2024
Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the tre2024
Inhibiting (α-v)(β-6) integrin2023
Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors2023
Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors2023
Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the tre2023